Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology
- PMID: 15480663
- DOI: 10.1007/s00277-004-0939-7
Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology
Abstract
While for most cancers incidence and mortality are decreasing, those of non-Hodgkin's lymphoma (NHL) are steadily increasing. Research to define reasons for this increase is extensive, but has not yet resolved them. We have conducted a literature analysis on trends regarding changes in the incidence, geographic distribution, and etiologic factors of NHL. From our own and previous analyses, an increasing NHL incidence at a rate of 3-4% per year was observed for the 1970s and 1980s. This stabilized in the 1990s, nevertheless still with an annual rise of 1-2%, resulting in almost a doubling of the NHL incidence. This rise has been noted worldwide, particularly in elderly persons >55 years. Concerning gender subgroups, a male predominance throughout all age groups is apparent. Although the NHL incidence has historically been higher in whites than blacks, disproportional increases have recently been observed in the latter group. Increases in high-grade NHL and extranodal disease are predominant. Differences in geographic distribution are striking for follicular lymphoma, which is more common in Western countries than elsewhere. Asians have higher rates of aggressive NHL, T-cell lymphomas, and extranodal disease. In the Middle East, high rates of intestinal extranodal disease are observed, whereas in Africa, endemic Burkitt's lymphoma accounts for a substantial proportion. Risks for developing NHL include immunosuppression and a causal link between infectious agents, and lymphomagenesis has also been determined, particularly for human T-cell leukemia/lymphoma virus type 1 (HTLV-1), Epstein-Barr virus (EBV), and Helicobacter pylori infections. Exposure to environmental agents and occupational risks have been studied; however, their significance is as yet uncertain.
Similar articles
-
[Epidemiology of non-Hodgkin's lymphoma: recent data].Bull Cancer. 1999 Jun;86(6):529-36. Bull Cancer. 1999. PMID: 10417426 French.
-
The epidemiology of non-Hodgkin lymphoma.Pathology. 2005 Dec;37(6):409-19. doi: 10.1080/00313020500370192. Pathology. 2005. PMID: 16373224 Review.
-
Non-Hodgkin's lymphomas in Asia.Hematol Oncol Clin North Am. 1991 Oct;5(5):983-1001. Hematol Oncol Clin North Am. 1991. PMID: 1938764 Review.
-
Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.Haematologica. 2001 Jan;86(1):58-63. Haematologica. 2001. PMID: 11146572
-
The epidemiology of non-Hodgkin's lymphoma.Oncogene. 2004 Aug 23;23(38):6524-34. doi: 10.1038/sj.onc.1207843. Oncogene. 2004. PMID: 15322522 Review.
Cited by
-
The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender.Ann Epidemiol. 2012 Dec;22(12):855-62. doi: 10.1016/j.annepidem.2012.10.002. Epub 2012 Nov 10. Ann Epidemiol. 2012. PMID: 23146413 Free PMC article.
-
The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells.Diagnostics (Basel). 2022 Feb 23;12(3):573. doi: 10.3390/diagnostics12030573. Diagnostics (Basel). 2022. PMID: 35328127 Free PMC article. Review.
-
PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males.BMC Med Genet. 2010 Mar 3;11:38. doi: 10.1186/1471-2350-11-38. BMC Med Genet. 2010. PMID: 20196871 Free PMC article.
-
Outcomes in lymphoma patients with obstructive jaundice: a cancer center experience.Dig Dis Sci. 2010 Nov;55(11):3271-7. doi: 10.1007/s10620-010-1310-6. Epub 2010 Jul 15. Dig Dis Sci. 2010. PMID: 20632106
-
Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018.Popul Health Metr. 2014 Mar 4;12(1):4. doi: 10.1186/1478-7954-12-4. Popul Health Metr. 2014. PMID: 24593777 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources